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Background: Appetite-modulating hormones ghrelin and leptin might be relevant to asthma with their
pro-inflammatory effects, and calprotectin has been recognized as a promising marker of inflammation. The
purpose of this study was to explore whether asthma, atopy and lung functions has a relation with serum levels of
leptin, ghrelin and calprotectin as inflammatory markers in children.
Methods: A cross-sectional study was performed by searching the doctor diagnosed asthma through
questionnaires filled in by parents who were phoned, and children were invited to supply fasting blood samples
in order to measure serum levels of leptin, ghrelin and calprotectin, and to perform skin prick test and spirometry.
Participants were divided into Group 1, children with previous diagnosis of asthma, and Group 2, children without
previous diagnosis of asthma.
Results: One thousand and two hundred questionnaires were distributed and 589 of them were returned filled in.
Out of 74 children whose parents accepted to participate in the study, 23 were in Group 1 and 51 were in Group
2. There was no statistical difference in serum levels of leptin, ghrelin, calprotectin, forced expiratory volume in
one second (FEV1), forced vital capacity (FVC), peak expiratory flow (PEF) , forced expiratory flow between 25 and
75% of vital capacity (FEF25-75) values , and skin prick test results between the two groups (p values are 0.39, 0.72,
0.5, 0.17, 0.5, 0.27, 0.18, and 0.81 respectively).
Conclusion: In this study the inflammation in asthmatic children could not be shown by using serum leptin,
ghrelin and calprotectin levels and this is possibly due to the low number of children with ever asthma and equal
skin prick test positivity in both groups. This study is the first study aimed to show the relation between serum
calprotectin levels and inflammation in asthma. As this study was a cross-sectional study, further prospectively
designed randomized controlled studies are necessary to show the association of these markers and inflammation
in asthma.
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Asthma is a chronic inflammatory condition of the air-
ways associated with airway hyper-responsiveness that
leads to recurrent episodic of airflow obstruction within
the lungs. Although the cause of childhood asthma has not
been definitely determined, current research includes a
combination of environmental respiratory exposures, such
as inhaled allergens, respiratory viral infections, air pollu-
tants, and genetic vulnerabilities.* Correspondence: drncobanoglu@yahoo.com
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distribution, and reproduction in any mediumBoth the human and murine studies showed that the
pro-inflammatory effects of recently discovered appetite-
modulating hormones ghrelin and leptin might be rele-
vant to asthma [1-3]. Both hormones have some immuno-
modulatory effects and counteract each other with regard
to the production of pro-inflammatory cytokines such as
TNF-α and IL-1β on human lymphocytes in vitro [4]. On
the other hand, inflammation decreases serum ghrelin
levels [5] and increases serum leptin levels [6]. Calpro-
tectin has been recognized as a promising marker of
inflammation [7,8]. The serum level of calprotectin may
be a very sensitive non-specific inflammatory marker in
various clinical settings and has been proposed for thetral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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has not been searched whether serum calprotectin levels
with leptin and ghrelin levels could be used to detect the
inflammation related to childhood asthma. The purpose of
this study therefore was to explore whether asthma, atopy
and lung functions have a relation with serum levels of lep-
tin, ghrelin and calprotectin as inflammatory markers in
children.
Methods
A cross-sectional study was performed from May 1 to
September 1, 2011, in summer time, among the first to
fifth grade students of a randomly selected primary school
in Nicosia. The investigation was coordinated by Near
East University Faculty of Medicine Department of Paedi-
atrics and approved by the Ethics Committee of this fac-
ulty. The International Study of Asthma and Allergies in
Childhood (ISAAC) questionnaire, translated into Turkish
previously [10], was distributed to all students to be filled
in by their parents and returned to school. Then all re-
sponders were phoned, given information about the study
and their children were invited to participate in this study.
Children with any chronic disease and acute infection
were excluded from the study. After obtaining written in-
formed consents from their parents, fasting blood samples
of participant children were drawn to measure serum lep-
tin, ghrelin and calprotectin levels. Body mass indexes
(BMI) of the children were calculated as weight (kg)/
height2 (m). Skin prick test to aeroallergens and spirom-
etry were performed to all participant children. Children
were divided into two groups according to the responses
to the question in ISAAC questionnaire “Has your child
ever been diagnosed in asthma?” children were divided
into two groups: group 1 included the children with previ-
ous diagnosis of asthma, while group 2 those children
without previous diagnosis of asthma. The data of these
two groups were compared.
Laboratory procedures
All laboratory investigations were performed by a re-
searcher unaware of the asthma diagnosis of the children.
Five mL samples of peripheral venous blood samples were
obtained from all children. Each blood sample was left to
coagulate for 30 minutes, then centrifuged for 15 minutes
at 10000 rpm and the extracted serum was collected and
stored at −20°C until analysis.
Leptin (ng/mL) and ghrelin (ng/mL) were measured
by EIA ( DRG Diagnostics, Inc., Marburg, Germany
and Raybiotech, Inc., GA, USA respectively), whereas
caprotectin (ng/mL) was measured by ELISA (Human
Calprotectin ELISA kit, Cusabio Biotech, China) in
serum samples. The methods of measurement were
carried out according to the manufacturer instructions.
The standard curves are created by reducing the dateusing computer software (Softmax Pro.) capable of gen-
erating four parameter logistic (4PL) curve-fit. The lower
detection limits were 1 ng/mL for leptin, 161 pg/mL for
ghrelin, and 2 ng/mL for calprotectin. The values under
lower detection limits were accepted as 0 ng/mL.Skin prick test
Skin prick tests to aeroallergens were performed by a re-
searcher unaware of the asthma diagnosis of the children
with 24 common aeroallergens belonging to 5 groups;
mites (Dermatophagoides farinae, Dermatophagoides
pteronyssinus), molds (Alternaria, Aspergillus mix, Peni-
cillium mix, Candida albicans), pollens (Betulaceae,
Aesculus Hippo, Olea Europea, Plantago, Artemisia,
Parietaria, Secale cereale, Triticum vulgaris, Zea mays,
mixture of 5 grasses), animal epithelia (feathers mixture
[duck, goose and hen], cat hair, dog hair) and insects
(cockroach) (Stallergenes, Antony, France). Histamine
and saline were used as positive and negative controls,
respectively. A drop of each allergen extract was placed
on the volar surface of the left forearm and was pene-
trated with a stallerpoint. After 15 minutes, the wheal
reaction was measured as the mean of the longest diam-
eter and the diameter perpendicular to it. A wheal diam-
eter of at least 3 mm greater than those of the negative
controls was considered as positive.Lung function testing
Lung function was assessed with a spirometer (Vmax
Encore 22, California, USA). At least three reproducible
blows with maximum difference between two best mea-
surements of 5% or 150 ml were obtained and the
highest value of these three attempts was accepted. Mea-
surements of forced expiratory volume in one second
(FEV1), forced vital capacity (FVC), peak expiratory flow
(PEF) and forced expiratory flow between 25 and 75% of
vital capacity (FEF25-75) were compared to normal
values, standardized for gender, height and age, and were
expressed as a percentage of the predicted value.Statistical analysis
The Pearson chi-square test was performed in the
case of categorical variables. Mean ± SD values were
calculated for normally distributed data and median
values for non-normally distributed data. Unpaired t-
tests were used to test differences between groups for
normally distributed variables. The Mann–Whitney
U-test and Spearman’s rho test were used for non-
parametric variables. p ≤ 0.05 was considered statisti-
cally significant. Statistical analyses were performed
by using the SPSS software package for Windows
(release 17.0.0; SPSS Inc., Chicago, Ill, USA).
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One thousand and two hundred ISAAC questionnaires
were distributed and 580 of them returned filled in. Parents
of 74 children accepted to participate in the study follow-
ing the invitation and the74 children (23 in Group 1 and
51 in Group 2) were recruited to the study. There was no
statistical difference in serum levels of leptin, ghrelin,
calprotectin, FEV1, FVC, PEF , FEF25-75 values , and skin
prick test results between the two groups (p was 0.39, 0.72,
0.5, 0.17, 0.5, 0.27, 0.18, and 0.81 respectively). Data are
presented in Table 1. Serum levels of leptin, ghrelin and
calprotectin were also compared after dividing children
into two new groups according to the results of skin prick
tests: “Skin prick test positive” (SPT+) (n = 47) and “Skin
prick test negative” (SPT-) (n = 24), and again there was
no statistically significant difference between the two
groups. Data are presented in Table 2.
There was a significant correlation between BMI and
serum leptin levels (p < 0.001 and correlation coefficient =
0.85) (Figure 1) of all participants, but not between BMI
and serum ghrelin and calprotectin levels (p values are
0.27 and 1.0, correlation coefficients are 0.12 and 0.00
respectively).
Discussion
In this cross-sectional study, no differences in serum levels
of leptin, ghrelin and calprotectin were detected between
children with and without a previous diagnosis of asthma
according to ISAAC questionnaire.
Previously, a growing number of studies have exam-
ined the potential role of leptin in the respiratory sys-
tem. Although leptin is synthesized and secreted
mainly by white adipose tissue [11], accumulative data
have identified foetal and adult lung tissue as leptinTable 1 Comparison of BMI, gender, age, serum levels of lept
prick tests in asthmatic and non-asthmatic children
Gro
BMI (mean ± SD)
Gender (girl)(n)(%)
Age (year)(mean ± SD)
Leptin (ng/mL) (median [minimum-maximum]) 5
Ghrelin (ng/mL) (median [minimum-maximum]) 30
Calprotectin (ng/mL) (median [minimum-maximum]) 1
FEV1% (median [minimum-maximum]) 1
FVC% (median [minimum-maximum]) 9
PEF% (median [minimum-maximum]) 9
FEF25-75% (median [minimum-maximum]) 1
Skin prick test positive (n) (%)
BMI body mass index, FEF25-75 forced expiratory flow between 25 and 75% of vital c
PEF peak expiratory flow.responsive and producing organs. Also, leptin’s involve-
ment in pulmonary homeostasis has become increasingly
evident [12-15]. Leptin and leptin receptors are expressed
by the lung [12,16]. Besides its proinflammatory systemic
effects, leptin negatively modulates the function of regula-
tory T cells that are associated with asthma [17], and pro-
mote Th1 proliferation with increased production of
interferon-γ [18,19]. Recent in vitro studies indicate that
leptin also stimulates release of vascular endothelial growth
factor by airway smooth muscle cells [20], although it does
not affect airway smooth muscle cell proliferation [13]. Vas-
cular endothelial growth factor may stimulate subepithelial
neovascularization and vascular permeability, a key finding
in asthma [20]. In vitro studies have documented that leptin
can significantly up-regulate the cell surface expression of
intracellular adhesion molecule ICAM-1 and CD18 and
suppress those of ICAM-3 and L-selectin in eosinophils
[21], while it augments alveolar macrophage leukotriene
synthesis [22]. The latter results suggest that leptin may in-
duce accumulation of eosinophils and may enhance inflam-
matory processes at sites such as the lung or the airways,
thereby increasing to some extent allergic airway responses
[21,22]. A causal role for leptin in asthma is supported by
murine studies: the administration of exogenous leptin in
leptin-deficient mice augments airway hyperreactivity fol-
lowing allergen challenge, as well as lung inflammation fol-
lowing ozone exposure [1,23]. Human data are, however,
currently inconclusive regarding the independent associ-
ation between serum leptin concentration and risk of
asthma [3,24,25]. A large population-based study by Jartti
et al. [26] used a sequential nested case control study de-
sign set within an established Finnish cohort and did not
show an independent association between asthma and
serum leptin concentrations. Some children studies within, ghrelin and calprotectin levels, lung function and skin
up 1 (n = 23) Group 2 (n = 51) p value
20.3 ± 4.4 19.1 ± 4.2 0.82
9 (39%) 31 (60%) 0.08
8.2 ± 1.2 8.8 ± 1.4 0.09
.3 (0.4-27.4) 8.8 (0.3-31.3) 0.39
.9 (1.9-138.5) 26.9 (1.0-436.3) 0.72
.0 (0.0-106.8) 1.5 (0.0-27.5) 0.5
07 (76–126) 101 (79–130) 0.17
9 (73–121) 97 (36–173) 0.5
9 (72–126) 96 (78–126) 0.27
11 (39–177) 95 (65–129) 0.18
32 (65%) 15 (68%) 0.81
apacity, FEV1 forced expiratory flow in one second, FVC forced vital capacity,
Table 2 Comparison of serum levels of leptin, ghrelin and calprotectin levels according to the skin prick test results
SPT + (n = 47) SPT- (n = 24) p value
Leptin (ng/mL) (median [minimum-maximum]) 5.2 (0.2-27.5) 5.7 (0.8-20.9) 0.92
Ghrelin (ng/mL) (median [minimum-maximum]) 30.9 (1.9-138.5) 26.9 (1.0-436.3) 0.98
Calprotectin (ng/mL) (median [minimum-maximum]) 1.0 (0.0-19.4) 0.5 (0.0-106.8) 0.62
SPT+, Skin prick test positive, SPT-, Skin prick test negative.
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ation [3,24], while others not [27]. In our cross-sectional
study, we also did not show an correlation between asthma
(both according to self declaration of doctor diagnosed
asthma or to the results of skin prick tests) and serum lep-
tin concentration.
Undoubtedly, leptin has emerged in the literature as a
multifunctional hormone with versatile activities and com-
plex counteractions with other cytokines and adipokines.
However, decoding its pulmonary impact is not an easy
task, since the role of leptin cannot always be separated
from obesity and the biology of adipose tissue. Recent epi-
demiological studies have demonstrated that the prevalence
of asthma and obesity are both increasing concomitantly,
suggesting that these factors may be causally related [28].
Accumulating evidence has implicated systemic changes in
immune function in the development of obesity; several
obesity-related hormones and cytokines may lead to airway
hyper-responsiveness [1,29,30]. In our study there was no
difference between the BMIs of asthmatic and non-
asthmatic children, so we could eliminate the effect of obes-
ity on the serum levels of leptin.
In the present study, we paid special attention to the re-
cently discovered hormones ghrelin and leptin, because
both hormones seem to exert a wide range of effects on





Figure 1 Correlation between the serum levels of leptin and BMI in aghrelin dose-dependently inhibits proliferation of anti-
CD3-activated murine T cells and non-specifically inhibits
both T-helper 1 (Th1; IL-1 and IFN-γ) and Th2 (IL-4 and
IL-19) cytokine mRNA expression [32]. In a previous study
on children, Matsuda et al. [2] showed a significant correl-
ation between the levels of plasma ghrelin and leptin levels
and BMI. They found that overweight children had signifi-
cantly higher IgE concentrations than non-obese children,
and also observed significant correlation between serum
IgE and plasma concentrations of ghrelin and leptin. These
findings suggested the possibility that obesity-related hor-
mones may represent a link between obesity and allergic
disorders. Nevertheless, Okamatsu et al. [33] found that
serum leptin had a significant positive correlation with BMI
while plasma ghrelin did not correlate with it. Surprisingly,
a significant inverse correlation between plasma concentra-
tions of ghrelin and serum immunoglobulin concentrations
was found in their study. In the present study, we did not
find a difference between the serum ghrelin levels of asth-
matic and non-asthmatic children, and there was no correl-
ation between serum ghrelin levels and BMI in the whole
group.
Elevated serum calprotectin (synonyms in the literature:
aka MRP8/14, calgranulin, cystic fibrosis-associated antigen,
and S100) levels are found in a variety of chronic inflamma-
tory conditions, including rheumatoid arthritis, allograft25,00 30,00
Observed
Linear
ll participant children. (p < 0.001 and correlation coefficient = 0.85).
Cobanoglu et al. Multidisciplinary Respiratory Medicine 2013, 8:62 Page 5 of 6
http://www.mrmjournal.com/content/8/1/62rejections, inflammatory bowel and lung diseases, and en-
vironmental tobacco smoke-exposure [34]. Asthma is a
chronic inflammatory disease, therefore we compared the
serum calprotectin levels of asthmatic and non-asthmatic
children demonstrating no significant difference between
the two groups. Possibly, we could not detect any differ-
ence between groups due to the low number of children
with asthma. In addition, skin prick test positivity was
equal in both groups, and this might be another reason
why no differences were detected between two groups. It
could be better to include children with current diagnosis
of asthma rather than responses to questionnaires.
There were no statistically significant differences in terms
of spirometric data and skin prick test results between the
two groups. Because our study was based on a screening
questionnaire only, it could be that, absence of current
asthma and therefore allergic inflammation in some of the
children at the time of study might have influenced the re-
sults. Possibly, monitoring inflammatory markers during
exacerbations of asthma could be more useful.
Although we could not find any statistical difference
between the two groups in terms of serum levels of lep-
tin, there was a significant correlation between BMI and
serum leptin levels. As leptin is synthesized and secreted
mainly by white adipose tissue this correlation was ra-
tional and compatible with previous studies.Conclusions
It is indisputable that asthma is an inflammatory condition
although we could not show the inflammation by using
serum leptin, ghrelin and calprotectin levels in asthmatic
children. According to the current literature, this is the first
study aimed to show the association of serum calprotectin
with asthma. As our study was a cross-sectional study, fur-
ther prospectively designed randomized controlled studies
are necessary in order to show the association between
these markers and inflammation in asthma.Competing interests
The authors declared that they have no competing interests.Authors’ contributions
NC participated in the design of the study, performed statistical analysis and
drafted the manuscript. NG and CD participated in coordination and helped
to draft the manuscript. NNB participated in the design of the study and
helped to draft the manuscript.
Author details
1Department of Pediatric Pulmonology, Near East University, Faculty of
Medicine, Nicosia, North Cyprus. 2Department of Pediatric Allergy and
Immunology, Near East University, Faculty of Medicine, Nicosia, North Cyprus.
3Department of Pediatrics, Near East University, Faculty of Medicine, Nicosia,
North Cyprus.
Received: 16 April 2013 Accepted: 6 August 2013
Published: 25 September 2013References
1. Shore SA, Schwartzman IN, Mellema MA, Flynt L, Imirich A, Johnston RA:
Effect of leptin on allergic airway responses in mice. J Allergy Clin
Immunol 2005, 115:103–109.
2. Matsuda K, Nishi Y, Okamatsu Y, Kojima M, Matsuishi T: Ghrelin and
leptin: a link between obesity and allergy? J Allergy Clin Immunol 2006,
117:705–706.
3. Guler N, Kirerleri E, Ones U, Tamay Z, Salmayenli N, Darendeliler F: Leptin:
does it have any role in childhood asthma? J Allergy Clin Immunol 2004,
114:254–259.
4. Dixit VD, Schaffer EM, Pyle RS, Collins GD, Sakthivel SK, Palaniappan R, Lillard
JW Jr, Taub DD: Ghrelin inhibits leptin- and activation induced
proinflammatory cytokine expression by human monocytes and T cells.
J Clin Invest 2004, 114:57–66.
5. Striz I, Trebichavsky I: Calprotectin-a pleiotropic molecule in acute and
chronic inflammation. Physiol Res 2004, 53:245–253.
6. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe
GD, Pepys MB, Gudnason V: C-reactive protein and other circulating
markers of inflammation in the prediction of coronary heart disease.
N Engl J Med 2004, 350:1387–1397.
7. Foell D, Roth J: Proinflammatory S100 proteins in arthritis and
autoimmune disease. Arthritis Rheum 2004, 50:3762–3771.
8. Healy AM, Pickard MD, Pradhan AD, Wang Y, Chen Z, Croce K, Sakuma M,
Shi C, Zago AC, Garasic C, Damokosh AI, Dowie TL, Poisson L, Lillie J, Libby
P, Ridker PM, Simon DI: Platelet expression profiling and clinical
validation of myeloid-related protein-114 as a novel determinant of
cardiovascular events. Circulation 2006, 113:2278–2284.
9. Croce K, Gao H, Wang Y, Mooroka T, Sakuma M, Shi C, Sukhova GK, Packard
RR, Hogg N, Libby P, Simon DI: Myeloid-related protein-8/14 is critical for
the biological response to vascular injury. Circulation 2009, 120:427–436.
10. Ones U, Sapan N, Somer A, Disci R, Salman N, Guler N, Yalcin I: Prevalence
of childhood asthma in Istanbul, Turkey. Allergy 1997, 52:570–575.
11. Friedman JM, Halaas JL: Leptin and the regulation of body weight in
mammals. Nature 1998, 395:763–770.
12. Bruno A, Pace E, Chanez P, Gras D, Vachier I, Chiappara G, La Guardia M,
Gerbino S, Profita M, Gjomarkaj M: Leptin and leptin receptor expression
in asthma. J Allergy Clin Immunol 2009, 124:230–237.
13. Nair P, Radford K, Fanat A, Janssen LJ, Peters-Golden M, Cox PG: The effects
of leptin on airway smooth muscle responses. Am J Respir Cell Mol Biol
2008, 39:475–481.
14. Vernooy JH, Drummen NE, van Suylen RJ, Cloots RH, Möller GM, Bracke KR,
Zurderduyn S, Dentener MA, Bruselle GG, Hiemstra PS, Wouters EF:
Enhanced pulmonary leptin expression in patients with severe COPD
and asymptomatic smokers. Thorax 2009, 64:26–32.
15. Tsuchiya T, Shimuzu H, Horie T, Mori M: Expression of leptin receptor in
lung: leptin as a growth factor. Eur J Pharmacol 1999, 365:273–279.
16. Bergen HT, Cherlet TC, Manuel P, Scott JE: Identification of leptin
receptors in lung and isolated fetal type II cells. Am J Respir Cell Mol Biol
2002, 27:71–77.
17. Taleb S, Herbin O, Ait-Oufella H, Verreth W, Gourdy P, Barateau V, Merval R,
Esposito B, Clement K, Holvoet P, Tedgui A, Mallat Z: Defective leptin/leptin
receptor signaling improves regulatory T cell immune response and
protects mice from atherosclerosis. Arterioscler Thromb Vasc Biol 2007,
27:2691–2698.
18. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler I: Leptin
modulates the T-cell immune response and reverses starvation-induced
immunosupression. Nature 1998, 394:897–901.
19. Matarese G, La Cava A, Sanna V, Lord GM, Lechler RI, Fontana S, Zappacosta
S: Balancing susceptibility to infection and autoimmunity: a role for
leptin? Trends Immunol 2002, 23:182–187.
20. Shin JH, Kim JH, Lee WY, Shim JY: The expression of adiponectin
receptors and the effects of adiponectin and leptin on airway smooth
muscle cells. Yonsei Med J 2008, 49:804–810.
21. Wong CK, Cheung PF, Lam CW: Leptin-mediated cytokine release and
migration of eosinophils: implications for immunopathophysiology of
allergic inflammation. Eur J Immunol 2007, 37:2337–2348.
22. Mancuso P, Canetti C, Gottschalk A, Tithof PK, Peters-Golden M:
Leptin augments alveolar macrophage leukotriene synthesis by
increasing phospholipase activity and enhancing group IVC iPLA2
(cPLA2gamma) protein expression. Am J Physiol Lung Cell Mol Physiol
2004, 287:L497–L502.
Cobanoglu et al. Multidisciplinary Respiratory Medicine 2013, 8:62 Page 6 of 6
http://www.mrmjournal.com/content/8/1/6223. Shore SA, Rivera-Sanchez YM, Schwartzman IM, Johnston RA: Responses to
ozone are increased in obese mice. J Appl Physiol 2003, 95:938–945.
24. Nagel G, Koenig W, Rapp K, Wabitsch M, Zoellner I, Weiland SK:
Associations of adipokines with asthma, rhinoconjunctivitis, and eczema
in German schoolchildren. Pediatr Allergy Immunol 2009, 20:81–88.
25. Sood A, Ford ES, Camargo JA Jr: Association between leptin and asthma
in adults. Thorax 2006, 61:300–305.
26. Jartti T, Saarikoski L, Jartti L, Lisinen I, Jula A, Huupponen R, Viikari J, Raitakari
OT: Obesity, adipokines and asthma. Allergy 2009, 64:770–777.
27. Kim KW, Shin YH, Lee KE, Kim ES, Sohn MH, Kim KE: Relationship between
adipokines and manifestations of childhood asthma. Pediatr Allergy
Immunol 2008, 19:535–540.
28. Hancox RJ, Milne BJ, Poulton R, Taylor DR, Greene JM, McLachlan CR,
Cowan JO, Flannery EM, Herbison GP, Sears MR: Sex differences in the
relation between body mass index and asthma and atopy in a birth
cohort. Am J Respir Crit Care Med 2005, 171:440–445.
29. Shore SA, Fredberg JJ: Obesity, smooth muscle, and airway
hyperresponsiveness. J Allergy Clin Immunol 2005, 115:925–927.
30. Sood A: Does obesity weigh heavily on the health of human airway?
J Allergy Clin Immunol 2005, 115:921–924.
31. Tilg H, Moschen AR: Adipocytokines: mediators linking adipose tissue,
inflammation and immunity. Nat Rev Immunol 2006, 6:772–783.
32. Xia Q, Pang W, Pan H, Zheng Y, Kang JS, Zhu SG: Effects of ghrelin on the
proliferation and secretion of splenic T lymphocytes in mice. Regul Pept
2004, 122:173–178.
33. Okamatsu Y, Matsuda K, Hiramoto I, Tani H, Kimura K, Yada Y, Kakuma T,
Higuchi S, Kojima M, Matsuishi T: Ghrelin and leptin modulate immunity
and liver function in overweight children. Pediatr Int 2009, 51:9–13.
34. Roth J, Goebeler M, Sorg C: S100A8 and S100A9 in inflammatory diseases.
Lancet 2001, 357:1041.
doi:10.1186/2049-6958-8-62
Cite this article as: Cobanoglu et al.: Leptin, ghrelin and calprotectin:
inflammatory markers in childhood asthma?. Multidisciplinary Respiratory
Medicine 2013 8:62.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
